MENU
TNXP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Tonix Pharmaceuticals Holding (TNXP) Earnings Date & Reports

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering... Show more

A.I. Advisor
published Earnings

TNXP is expected to report earnings to rise 16.43% to -417 cents per share on March 16

Tonix Pharmaceuticals Holding TNXP Stock Earnings Reports
Q4'25
Est.
$-4.18
Q3'25
Est.
$-3.59
Q2'25
Beat
by $2.97
Q1'25
Beat
by $22.84
Q4'24
Missed
by $5.86
The last earnings report on November 10 showed earnings per share of -358 cents, meeting the estimate of -358 cents. With 695.75K shares outstanding, the current market capitalization sits at 189.84M.
View a ticker or compare two or three
TNXP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TNXP showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company which engages in developing and manufacturing pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
26 Main Street
Phone
+1 862 799-8599
Employees
103
Web
https://www.tonixpharma.com